用于诊断肺结核的新型血生物标志物
Camila P Sobrinho1, Luana E Araújo1, Rodrigo L Meira2
1Advanced Public Health Laboratory (LASP), Gonçalo Moniz Institute, Fiocruz, Salvador, Bahia, Brazil.
Tuberculosis (Edinburgh, Scotland)
|January 10, 2026
概括
血液中的新诊断标志物显示出检测肺结核 (TB) 的前景. 像IL-1RA和IL-18这样的生物标志物的组合有可能在初级保健机构中快速,负担得起的结核病诊断.
科学领域:
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
- 生物标志物发现发现
背景情况:
- 世界卫生组织 (WHO) 强调需要改善结核病 (TB) 诊断.
- 目前的结核病测试往往需要专门的设备,对于初级医疗保健机构来说并不理想.
- 需要血液等易于获取的样本来快速和负担得起的结核病诊断.
研究的目的:
- 评估肺结核全血培养中的34个生物标志物的诊断潜力.
- 确定特定的生物标志物组合,以区分结核病患者与非结核病患者.
- 评估这些标记物在未受刺激的和受 Mycobacterium tuberculosis (Mtb) 刺激的全血培养物中的有用性.
主要方法:
- 使用Luminex在来自结核病患者和症状呼吸道非结核病患者的全血培养超体中量化34种标志物.
- 对未受刺激和MTB刺激的培养进行分析.
- 用ROC曲线分析评估单个生物标志物和多标志物面板.
- 使用ELISA验证一个有前途的生物标志物组合 (IL-1RA + IL-18).
主要成果:
- 八个生物标志物 (IL-18,IL-1RA,IL-1β,IL-8,IP-10,MIP-1β,SDF-1α,TNF-α) 区分了结核病患者与未刺激培养中的对照人群 (AUC 0.71-0.82).
- 四个标记面板实现了更高的诊断准确性 (AUC 0.84-0.90,特异性> 90%,灵敏度70-75%).
- Mtb刺激没有提高诊断性能;IL-1RA + IL-18的ELISA验证得出AUC为0.76,灵敏度为62%,特异性为88%.
结论:
- 选择的生物标志物面板显示了肺结核诊断的潜力,特别是在未刺激的全血培养物中.
- 在ELISA验证时,IL-1RA和IL-18的组合表明了中等的诊断性能.
- 对生物标志物组合的进一步研究可能有助于预测结核病进展和监测治疗反应.
相关概念视频
Pulmonary Tuberculosis IV
469
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
469
Pulmonary Tuberculosis III
914
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
914
Pulmonary Tuberculosis I
817
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
817
Pulmonary Tuberculosis V
532
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
532
Pulmonary Tuberculosis II
1.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K
Pneumonia III: Complications and Assessment
772
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
772


